Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Pulse Biosciences, Inc (PLSE) had Return on Equity of -20.91% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.09M |
|
$-19.39M |
|
$0.28M |
|
$-0.19M |
|
$20.45M |
|
$-20.37M |
|
$0.98M |
|
$-19.39M |
|
$-19.39M |
|
$-19.39M |
|
$-19.39M |
|
$-19.39M |
|
$-19.39M |
|
$-20.37M |
|
$-20.11M |
|
67.39M |
|
67.39M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$97.16M |
|
$1.05M |
|
$11.61M |
|
$108.77M |
|
$9.70M |
|
-- |
|
$6.37M |
|
$16.07M |
|
$92.69M |
|
$89.16M |
|
$92.69M |
|
67.74M |
|
| Cash Flow Statement Financials | |
$-39.37M |
|
$-0.23M |
|
$16.77M |
|
$118.04M |
|
$95.21M |
|
$-22.82M |
|
$16.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-224.42% |
|
-23682.56% |
|
-23682.56% |
|
-- |
|
-22540.70% |
|
-22540.70% |
|
$-39.58M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
4.89 |
|
5.73 |
|
15.70 |
|
|
Return on Equity |
-20.91% |
-21.74% |
|
-17.82% |
|
-20.91% |
|
$1.37 |
|
$-0.59 |
|
$-0.58 |
|